PGAM2 and cardiac hypertrophy: These results clarify that PGAM2 is involved in the regulation of cardiac hypertrophy through modulation of HSP90, which provides a potential therapeutic target for the treatment of cardiac hypertrophy and HSP90-related dysfunctions.